Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

3.

Is there any role of intravenous iron for the treatment of anemia in cancer?

Gemici C, Yetmen O, Yaprak G, Ozden S, Tepetam H, Ozyurt H, Mayadagli A.

BMC Cancer. 2016 Aug 20;16(1):661. doi: 10.1186/s12885-016-2686-2.

4.

Antianemic Treatment of Cancer Patients in German Routine Practice: Data from a Prospective Cohort Study-The Tumor Anemia Registry.

Steinmetz T, Schröder J, Plath M, Link H, Vogt M, Frank M, Marschner N.

Anemia. 2016;2016:8057650. doi: 10.1155/2016/8057650.

5.

Efficacy of trabectedin in advanced soft tissue sarcoma: beyond lipo- and leiomyosarcoma.

De Sanctis R, Marrari A, Marchetti S, Mussi C, Balzarini L, Lutman FR, Daolio P, Bastoni S, Bertuzzi AF, Quagliuolo V, Santoro A.

Drug Des Devel Ther. 2015 Oct 27;9:5785-91. doi: 10.2147/DDDT.S92395. Erratum in: Drug Des Devel Ther. 2016;10:441.

6.

Approach to chemotherapy-associated thrombosis.

Oppelt P, Betbadal A, Nayak L.

Vasc Med. 2015 Apr;20(2):153-61. doi: 10.1177/1358863X14568705. Review.

7.

Onco-nephrology: an appraisal of the cancer and chronic kidney disease links.

Izzedine H, Perazella MA.

Nephrol Dial Transplant. 2015 Dec;30(12):1979-88. doi: 10.1093/ndt/gfu387. Review.

8.

Clinical practice guidelines and consensus statements in oncology--an assessment of their methodological quality.

Jacobs C, Graham ID, Makarski J, Chassé M, Fergusson D, Hutton B, Clemons M.

PLoS One. 2014 Oct 17;9(10):e110469. doi: 10.1371/journal.pone.0110469. Erratum in: PLoS One. 2014;9(12):e116267.

9.

A prospective randomized wait list control trial of intravenous iron sucrose in older adults with unexplained anemia and serum ferritin 20-200 ng/mL.

Price E, Artz AS, Barnhart H, Sapp S, Chelune G, Ershler WB, Walston JD, Gordeuk VR, Berger NA, Reuben D, Prchal J, Rao SV, Roy CN, Supiano MA, Schrier SL, Cohen HJ.

Blood Cells Mol Dis. 2014 Dec;53(4):221-30. doi: 10.1016/j.bcmd.2014.06.003.

10.

Chapter 3: Use of ESAs and other agents to treat anemia in CKD.

[No authors listed]

Kidney Int Suppl (2011). 2012 Aug;2(4):299-310. No abstract available.

11.

Pharmacovigilance in practice: erythropoiesis-stimulating agents.

Hedenus M, Ludwig H, Henry DH, Gasal E.

Cancer Med. 2014 Oct;3(5):1416-29. doi: 10.1002/cam4.275. Review.

12.

Effects of erythropoiesis-stimulating agents on fatigue- and anaemia-related symptoms in cancer patients: systematic review and meta-analyses of published and unpublished data.

Bohlius J, Tonia T, Nüesch E, Jüni P, Fey MF, Egger M, Bernhard J.

Br J Cancer. 2014 Jul 8;111(1):33-45. doi: 10.1038/bjc.2014.171. Review.

14.

Multiple myeloma in the very old: an IASIA conference report.

Tuchman SA, Shapiro GR, Ershler WB, Badros A, Cohen HJ, Dispenzieri A, Flores IQ, Kanapuru B, Jurivich D, Longo DL, Nourbakhsh A, Palumbo A, Walston J, Yates JW.

J Natl Cancer Inst. 2014 Apr 3;106(5). pii: dju067. doi: 10.1093/jnci/dju067.

15.

International Myeloma Working Group consensus statement for the management, treatment, and supportive care of patients with myeloma not eligible for standard autologous stem-cell transplantation.

Palumbo A, Rajkumar SV, San Miguel JF, Larocca A, Niesvizky R, Morgan G, Landgren O, Hajek R, Einsele H, Anderson KC, Dimopoulos MA, Richardson PG, Cavo M, Spencer A, Stewart AK, Shimizu K, Lonial S, Sonneveld P, Durie BG, Moreau P, Orlowski RZ.

J Clin Oncol. 2014 Feb 20;32(6):587-600. doi: 10.1200/JCO.2013.48.7934. Review.

16.

Post-diagnosis hemoglobin change associates with overall survival of multiple malignancies - results from a 14-year hospital-based cohort of lung, breast, colorectal, and liver cancers.

Wan S, Lai Y, Myers RE, Li B, Palazzo JP, Burkart AL, Chen G, Xing J, Yang H.

BMC Cancer. 2013 Jul 10;13:340. doi: 10.1186/1471-2407-13-340.

17.

A tale of two citizens: a State Attorney General and a hematologist facilitate translation of research into US Food and Drug Administration actions--a SONAR report.

Chen B, Restaino J, Norris L, Xirasagar S, Qureshi ZP, McKoy JM, Lopez IS, Trenery A, Murday A, Kahn A, Mattison DR, Ray P, Sartor O, Bennett CL.

J Oncol Pract. 2012 Nov;8(6):e158-67. doi: 10.1200/JOP.2011.000504.

18.

The role of intravenous iron in the treatment of anemia in cancer patients.

Steinmetz HT.

Ther Adv Hematol. 2012 Jun;3(3):177-91. doi: 10.1177/2040620712440071.

19.

Supportive therapy in medical therapy of head and neck tumors.

Link H.

GMS Curr Top Otorhinolaryngol Head Neck Surg. 2012;11:Doc01. doi: 10.3205/cto000083.

20.

Negative impact of pretreatment anemia on local control after neoadjuvant chemoradiotherapy and surgery for rectal cancer.

Lee H, Park HC, Park W, Choi DH, Kim YI, Park YS, Park JO, Chun HK, Lee WY, Kim HC, Yun SH, Cho YB, Park YA.

Radiat Oncol J. 2012 Sep;30(3):117-23. doi: 10.3857/roj.2012.30.3.117.

Items per page

Supplemental Content

Support Center